Risk Factors of Intraductal Papillary Mucinous Neoplasm of Pancreas in Health Screening Subjects

Risk Factors of Intraductal Papillary Mucinous Neoplasm of Pancreas in Health Screening Subjects - Risk Factors of Intraductal Papillary Mucinous Neoplasm of Pancreas in Health Screening Subjects

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040907

Enrollment

20000

Registered

2020-06-30

Start date

2012-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraductal Papillary Mucinous Neoplasm

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 15,859 healthy subjects underwent abdominal ultrasonography (US) between April 2012 and March 2013. In the cyst absent cases, those not achieving the complete image of whole pancreas were excluded. Finally, 9,363 subjects were included in this study. IPMN was defined as more than 5mm pancreatic cyst with the presence of communication to the main pancreatic duct or the presence of multilocular form. Multivariable logistic regression analysis was conducted to identify the risk factors of IPMN in comparison with the subjects without cysts, adjusted by clinical characteristics.

Exclusion criteria

Exclusion criteria: ago

Design outcomes

Primary

Measure	Time frame
Percentage of IPMN found by screening	—

Countries

Japan

Contacts

Public ContactTsuyoshi Fujita

Yodogawa Christian Hospital Department of Gastroenterology

tsuyofuji@gmail.com0120-364-489

Outcome results